REGENXBIO
RegisteredCombined Mark
Never miss important updates for REGENXBIO
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach
Ownership
RI
Address
9804 Medical Center Drive
Rockville, MD 20850
Critical Dates
First Use Date
Sep 1, 2014
Filing Date
Aug 9, 2023
Registration Date
Mar 4, 2025
Mark Descriptions
Goods
Class 5
Biotechnological platform technology, namely, biological nanoparticles, recombinant viruses, and adenoviruses for gene delivery to biological cells that includes recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, RNA interference (RNAi), and cell therapy
Mark Elements
Text Mark
REGENXBIO
Category
Trademark
Standard Characters
No
Color Claim
No
Drawing/Image Description
The mark consists of a cluster of circles of varying size which create a larger circle. The cluster of circles surround a circle with a triangular shape inside. The wording "REGENXBIO" in stylized form appears to right of the cluster of circles.
Design Search Codes
260116
260121
260131
260502
Trademark Timeline
First Use
Filing Date
Publication Date
Registration Date
USPTO Records
No documents found for this trademark.